Autor: "Liu, X." - OpacWWW

Skocz do pozycji: 1.

Tytuł:: MiR-574-5p activates human TLR8 to promote autoimmune signaling and lupus.
Autorzy:: Wang T; State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, Xiang'an, Xiamen, 361102, China.; The Key Laboratory of Urinary Tract Tumors and Calculi, Department of Urology, School of Medicine, The First Affiliated Hospital of Xiamen University, Xiamen University, Xiamen, 361003, China.
Song D; State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, Xiang'an, Xiamen, 361102, China.
Li X; Wuhu Hospital of East China Normal University, Wuhu, Anhui, 241000, China.; Kidney Health Institute, Health Science Center, East China Normal University, Minhang, Shanghai, 200241, China.; Department of Nephrology, The Second Hospital, Dalian Medical University, Dalian, 116144, China.
Luo Y; School of Nursing, The Third Military Medical University, Chongqing, 400038, China.
Yang D; State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, Xiang'an, Xiamen, 361102, China.
Liu X; Department of Nephrology, The Second Hospital, Dalian Medical University, Dalian, 116144, China.
Kong X; Department of Rheumatology, The Second Affiliated Hospital of Dalian Medical University, Dalian, 116023, China.
Xing Y; Department of Rheumatology, The Second Affiliated Hospital of Dalian Medical University, Dalian, 116023, China.
Bi S; State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, Xiang'an, Xiamen, 361102, China.
Zhang Y; State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, Xiang'an, Xiamen, 361102, China.
Hu T; College of Medicine, Xiamen University, Xiang'an, Xiamen, 361102, China.
Zhang Y; State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, Xiang'an, Xiamen, 361102, China.
Dai S; State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, Xiang'an, Xiamen, 361102, China.
Shao Z; State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, Xiang'an, Xiamen, 361102, China.
Chen D; State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, Xiang'an, Xiamen, 361102, China.
Hou J; State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, Xiang'an, Xiamen, 361102, China.
Ballestar E; Wuhu Hospital of East China Normal University, Wuhu, Anhui, 241000, China.; Kidney Health Institute, Health Science Center, East China Normal University, Minhang, Shanghai, 200241, China.; Epigenetics and Immune Disease Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, 08916, Spain.
Cai J; Department of Gastrointestinal Surgery, Institute of Gastrointestinal Oncology, Zhongshan Hospital of Xiamen University, Medical College of Xiamen University, Xiamen, Fujian, 361005, China. .
Zheng F; Wuhu Hospital of East China Normal University, Wuhu, Anhui, 241000, China. .; Kidney Health Institute, Health Science Center, East China Normal University, Minhang, Shanghai, 200241, China. .; Department of Nephrology, The Second Hospital, Dalian Medical University, Dalian, 116144, China. .; The Advanced Institute for Molecular Medicine, Dalian Medical University, Dalian, 116144, China. .
Yang JY; State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, Xiang'an, Xiamen, 361102, China. .; Wuhu Hospital of East China Normal University, Wuhu, Anhui, 241000, China. .; Kidney Health Institute, Health Science Center, East China Normal University, Minhang, Shanghai, 200241, China. .; Pokaż więcej
Źródło:: Cell communication and signaling : CCS [Cell Commun Signal] 2024 Apr 08; Vol. 22 (1), pp. 220. Date of Electronic Publication: 2024 Apr 08.
Typ publikacji:: Journal Article
MeSH Terms:: Lupus Nephritis*/genetics
MicroRNAs*/genetics
Humans ; Mice ; Animals ; Toll-Like Receptor 7/genetics ; Toll-Like Receptor 7/metabolism ; Toll-Like Receptor 8/genetics ; Toll-Like Receptor 8/metabolism ; Kidney/metabolism ; Mice, Transgenic

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: OsmiR319-OsPCF5 modulate resistance to brown planthopper in rice through association with MYB proteins.
Autorzy:: Sun B; Key Laboratory of Insect Developmental and Evolutionary Biology, CAS Center for Excellence in Molecular Plant Sciences, Institute of Plant Physiology and Ecology, Chinese Academy of Sciences, Shanghai, 200032, China.; University of Chinese Academy of Sciences, Beijing, 100049, China.
Shen Y; Key Laboratory of Insect Developmental and Evolutionary Biology, CAS Center for Excellence in Molecular Plant Sciences, Institute of Plant Physiology and Ecology, Chinese Academy of Sciences, Shanghai, 200032, China.; University of Chinese Academy of Sciences, Beijing, 100049, China.
Zhu L; Key Laboratory of Insect Developmental and Evolutionary Biology, CAS Center for Excellence in Molecular Plant Sciences, Institute of Plant Physiology and Ecology, Chinese Academy of Sciences, Shanghai, 200032, China.; University of Chinese Academy of Sciences, Beijing, 100049, China.
Yang X; Key Laboratory of Insect Developmental and Evolutionary Biology, CAS Center for Excellence in Molecular Plant Sciences, Institute of Plant Physiology and Ecology, Chinese Academy of Sciences, Shanghai, 200032, China.; University of Chinese Academy of Sciences, Beijing, 100049, China.
Liu X; National Engineering Research Center for Vegetables, Beijing Vegetable Research Center, Beijing Academy of Agriculture and Forestry Science, Beijing, 100097, People's Republic of China.
Li D; National Engineering Research Center for Vegetables, Beijing Vegetable Research Center, Beijing Academy of Agriculture and Forestry Science, Beijing, 100097, People's Republic of China.
Zhu M; Shanghai Key Laboratory of Plant Functional Genomics and Resources, Shanghai Chenshan Botanical Garden, Shanghai, 201602, China.
Miao X; Key Laboratory of Insect Developmental and Evolutionary Biology, CAS Center for Excellence in Molecular Plant Sciences, Institute of Plant Physiology and Ecology, Chinese Academy of Sciences, Shanghai, 200032, China.
Shi Z; Key Laboratory of Insect Developmental and Evolutionary Biology, CAS Center for Excellence in Molecular Plant Sciences, Institute of Plant Physiology and Ecology, Chinese Academy of Sciences, Shanghai, 200032, China. .; Pokaż więcej
Źródło:: BMC biology [BMC Biol] 2024 Mar 22; Vol. 22 (1), pp. 68. Date of Electronic Publication: 2024 Mar 22.
Typ publikacji:: Journal Article
MeSH Terms:: Oryza*/physiology
Hemiptera*/genetics
MicroRNAs*/genetics
MicroRNAs*/metabolism
Animals

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Bladder-cancer-derived exosomal circRNA_0013936 promotes suppressive immunity by up-regulating fatty acid transporter protein 2 and down-regulating receptor-interacting protein kinase 3 in PMN-MDSCs.
Autorzy:: Shi X; Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Pang S; Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Zhou J; Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Yan G; Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Gao R; Southern Medical University, Guangzhou, China.
Wu H; Southern Medical University, Guangzhou, China.
Wang Z; Southern Medical University, Guangzhou, China.
Wei Y; Southern Medical University, Guangzhou, China.
Liu X; Southern Medical University, Guangzhou, China.
Tan W; Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China. .; Pokaż więcej
Źródło:: Molecular cancer [Mol Cancer] 2024 Mar 09; Vol. 23 (1), pp. 52. Date of Electronic Publication: 2024 Mar 09.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: MicroRNAs*/genetics
MicroRNAs*/metabolism
Myeloid-Derived Suppressor Cells*/metabolism
RNA, Circular*/genetics
RNA, Circular*/metabolism
Urinary Bladder Neoplasms*/pathology
Humans ; CD8-Positive T-Lymphocytes/metabolism ; Fatty Acids/metabolism ; Protein Kinases/metabolism ; Urinary Bladder/metabolism ; Exosomes/genetics ; Coenzyme A Ligases/genetics ; Coenzyme A Ligases/metabolism ; Receptor-Interacting Protein Serine-Threonine Kinases/genetics ; Receptor-Interacting Protein Serine-Threonine Kinases/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Dysregulation and antimetastatic function of circLRIG1 modulated by miR-214-3p/LRIG1 axis in bladder carcinoma.
Autorzy:: Cheng S; Department of Clinical Laboratory, Shandong Provincial Third Hospital, Cheeloo College of Medicine, Shandong University, Jinan Xingqi Medical Laboratory Co., Ltd., 12 Wuyingshan Middle Road, Jinan, 250000, Shandong, China. .
Li C; Department of Digestive Oncology, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital and Institute, 44 Xiaoheyan Road, ShenyangLiaoning, 110042, China.
Liu L; Department of Digestive Oncology, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital and Institute, 44 Xiaoheyan Road, ShenyangLiaoning, 110042, China.
Liu X; Department of Clinical Laboratory, Shandong Provincial Third Hospital, Cheeloo College of Medicine, Shandong University, 12 Wuyingshan Middle Road, Jinan, 250000, Shandong, China.
Li M; Department of Clinical Laboratory, Shandong Provincial Third Hospital, Cheeloo College of Medicine, Shandong University, 12 Wuyingshan Middle Road, Jinan, 250000, Shandong, China.
Zhuo J; Department of Clinical Laboratory, Shandong Provincial Third Hospital, Cheeloo College of Medicine, Shandong University, 12 Wuyingshan Middle Road, Jinan, 250000, Shandong, China.
Wang J; Department of Clinical Laboratory, Shandong Provincial Third Hospital, Cheeloo College of Medicine, Shandong University, 12 Wuyingshan Middle Road, Jinan, 250000, Shandong, China.
Zheng W; Department of Emergency, Shandong Provincial Third Hospital, Cheeloo College of Medicine, Shandong University, 12 Wuyingshan Middle Road, Jinan, 250000, Shandong, China. .
Wang Z; Department of Pharmacy, Shanghai Eastern Hepatobiliary Surgery Hospital, Navy Military Medical University, 225 Changhai Road, Shanghai, 200000, China. .; Pokaż więcej
Źródło:: Biology direct [Biol Direct] 2024 Mar 07; Vol. 19 (1), pp. 20. Date of Electronic Publication: 2024 Mar 07.
Typ publikacji:: Journal Article
MeSH Terms:: MicroRNAs*/genetics
MicroRNAs*/metabolism
Urinary Bladder Neoplasms*/genetics
Urinary Bladder Neoplasms*/metabolism
Urinary Bladder Neoplasms*/pathology
Carcinoma*/genetics
Humans ; Urinary Bladder/metabolism ; Urinary Bladder/pathology ; Cell Line, Tumor ; Cell Proliferation/genetics ; Cell Movement ; Gene Expression Regulation, Neoplastic ; Membrane Glycoproteins/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: MiR-203 improves cardiac dysfunction by targeting PARP1-NAD axis in aging murine.
Autorzy:: Zhao L; Department of Pharmacology (State-Province Key Laboratories of Biomedicine- Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, China.
Tang P; Department of Pharmacology (State-Province Key Laboratories of Biomedicine- Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, China.
Lin Y; Department of Pharmacology (State-Province Key Laboratories of Biomedicine- Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, China.
Du M; Department of Pharmacology (State-Province Key Laboratories of Biomedicine- Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, China.
Li H; Department of Pharmacology (State-Province Key Laboratories of Biomedicine- Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, China.
Jiang L; Department of Pharmacy, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, China.
Xu H; Department of Pharmacology (State-Province Key Laboratories of Biomedicine- Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, China.
Sun H; Department of Pharmacology (State-Province Key Laboratories of Biomedicine- Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, China.
Han J; Department of Pharmacy, Caoxian People's Hospital, Heze, China.
Sun Z; Department of Pharmacology (State-Province Key Laboratories of Biomedicine- Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, China.
Xu R; Department of Pharmacology (State-Province Key Laboratories of Biomedicine- Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, China.
Lou H; Department of Pharmacology (State-Province Key Laboratories of Biomedicine- Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, China.
Chen Z; Department of Pharmacology (State-Province Key Laboratories of Biomedicine- Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, China.
Kopylov P; Department of Preventive and Emergency Cardiology, Sechenov First Moscow State Medical University, Moscow, Russian Federation.
Liu X; Department of Pharmacology (State-Province Key Laboratories of Biomedicine- Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, China.; National Key Laboratory of Frigid Zone Cardiovascular Diseases (NKLFZCD), Harbin, China.; Research Unit of Noninfectious Chronic Diseases in Frigid Zone, Chinese Academy of Medical Sciences, Harbin, China.
Zhang Y; Department of Pharmacology (State-Province Key Laboratories of Biomedicine- Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, China.; National Key Laboratory of Frigid Zone Cardiovascular Diseases (NKLFZCD), Harbin, China.; Research Unit of Noninfectious Chronic Diseases in Frigid Zone, Chinese Academy of Medical Sciences, Harbin, China.; Institute of Metabolic Disease, Heilongjiang Academy of Medical Science, Harbin, China.; Pokaż więcej
Źródło:: Aging cell [Aging Cell] 2024 Mar; Vol. 23 (3), pp. e14063. Date of Electronic Publication: 2023 Dec 14.
Typ publikacji:: Journal Article
MeSH Terms:: MicroRNAs*/genetics
MicroRNAs*/metabolism
Heart Diseases*
Mice ; Humans ; Animals ; Aged ; NAD/metabolism ; Aging/genetics ; Aging/metabolism ; Myocytes, Cardiac/metabolism ; Cellular Senescence/genetics ; Mice, Transgenic ; Poly (ADP-Ribose) Polymerase-1/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Elucidating hepatocellular carcinoma progression: a novel prognostic miRNA-mRNA network and signature analysis.
Autorzy:: Wang F; Clinical Research Center, Shijiazhuang Fifth Hospital, Shijiazhuang, Hebei, China.
Kang X; Clinical Research Center, Shijiazhuang Fifth Hospital, Shijiazhuang, Hebei, China.
Li Y; Clinical Research Center, Shijiazhuang Fifth Hospital, Shijiazhuang, Hebei, China.
Lu J; Clinical Research Center, Shijiazhuang Fifth Hospital, Shijiazhuang, Hebei, China.
Liu X; Clinical Research Center, Shijiazhuang Fifth Hospital, Shijiazhuang, Hebei, China.
Yan H; Clinical Research Center, Shijiazhuang Fifth Hospital, Shijiazhuang, Hebei, China. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Feb 29; Vol. 14 (1), pp. 5042. Date of Electronic Publication: 2024 Feb 29.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Hepatocellular*/genetics
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/genetics
Liver Neoplasms*/pathology
MicroRNAs*/genetics
MicroRNAs*/metabolism
Humans ; Prognosis ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; Gene Regulatory Networks

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Developing Folate-Conjugated miR-34a Therapeutic for Prostate Cancer: Challenges and Promises.
Autorzy:: Li WJ; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.; Experimental Therapeutics (ET) Graduate Program, Roswell Park Comprehensive Cancer Center and the University at Buffalo, Buffalo, NY 14263, USA.
Wang Y; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
Liu X; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
Wu S; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
Wang M; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
Turowski SG; Department of Cell Stress Biology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
Spernyak JA; Department of Cell Stress Biology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
Tracz A; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
Abdelaal AM; Department of Biological Sciences, Purdue University, West Lafayette, IN 47907, USA.
Sudarshan K; Department of Biological Sciences, Purdue University, West Lafayette, IN 47907, USA.
Puzanov I; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
Chatta G; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
Kasinski AL; Department of Biological Sciences, Purdue University, West Lafayette, IN 47907, USA.
Tang DG; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.; Experimental Therapeutics (ET) Graduate Program, Roswell Park Comprehensive Cancer Center and the University at Buffalo, Buffalo, NY 14263, USA.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Feb 09; Vol. 25 (4). Date of Electronic Publication: 2024 Feb 09.
Typ publikacji:: Journal Article
MeSH Terms:: Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
MicroRNAs*/metabolism
MicroRNAs*/therapeutic use
Prostatic Neoplasms*/drug therapy
Prostatic Neoplasms*/genetics
Folic Acid*/pharmacology
Folic Acid*/therapeutic use
Humans ; Male ; Cell Line, Tumor ; Cell Proliferation/genetics ; Folate Receptor 1/genetics ; Folate Receptor 1/metabolism ; Folate Receptor 1/therapeutic use ; Gene Expression Regulation, Neoplastic ; Ligands

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Identification and analysis of key circRNAs in the mouse embryonic ovary provides insight into primordial follicle development.
Autorzy:: Wang X; Key Laboratory of Ministry of Education for Conservation and Utilization of Special Biological Resources in the Western, Ningxia University, Yinchuan, Ningxia, 750021, China.; School of Life Sciences, Ningxia University, Yinchuan, Ningxia, 750021, China.
Zhang Y; Key Laboratory of Ministry of Education for Conservation and Utilization of Special Biological Resources in the Western, Ningxia University, Yinchuan, Ningxia, 750021, China.; School of Life Sciences, Ningxia University, Yinchuan, Ningxia, 750021, China.
Yu J; Key Laboratory of Ministry of Education for Conservation and Utilization of Special Biological Resources in the Western, Ningxia University, Yinchuan, Ningxia, 750021, China.; School of Life Sciences, Ningxia University, Yinchuan, Ningxia, 750021, China.
Ma Y; Key Laboratory of Ministry of Education for Conservation and Utilization of Special Biological Resources in the Western, Ningxia University, Yinchuan, Ningxia, 750021, China.; School of Life Sciences, Ningxia University, Yinchuan, Ningxia, 750021, China.
Xu Y; Key Laboratory of Ministry of Education for Conservation and Utilization of Special Biological Resources in the Western, Ningxia University, Yinchuan, Ningxia, 750021, China.; School of Life Sciences, Ningxia University, Yinchuan, Ningxia, 750021, China.
Shi J; Key Laboratory of Ministry of Education for Conservation and Utilization of Special Biological Resources in the Western, Ningxia University, Yinchuan, Ningxia, 750021, China.; School of Life Sciences, Ningxia University, Yinchuan, Ningxia, 750021, China.
Qi Z; Key Laboratory of Ministry of Education for Conservation and Utilization of Special Biological Resources in the Western, Ningxia University, Yinchuan, Ningxia, 750021, China.; School of Life Sciences, Ningxia University, Yinchuan, Ningxia, 750021, China.
Liu X; Key Laboratory of Ministry of Education for Conservation and Utilization of Special Biological Resources in the Western, Ningxia University, Yinchuan, Ningxia, 750021, China. .; School of Life Sciences, Ningxia University, Yinchuan, Ningxia, 750021, China. .; Pokaż więcej
Źródło:: BMC genomics [BMC Genomics] 2024 Feb 03; Vol. 25 (1), pp. 139. Date of Electronic Publication: 2024 Feb 03.
Typ publikacji:: Journal Article
MeSH Terms:: RNA, Circular*/genetics
RNA, Circular*/metabolism
MicroRNAs*/genetics
Female ; Animals ; Mice ; Ovary/metabolism ; Phosphatidylinositol 3-Kinases ; RNA, Messenger ; Mammals/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Role of a novel circRNA-CGNL1 in regulating pancreatic cancer progression via NUDT4-HDAC4-RUNX2-GAMT-mediated apoptosis.
Autorzy:: Yuan H; Department of General Surgery, Pancreas Centre, the First Affiliated Hospital With Nanjing Medical University, 300 Guangzhou Road, Nanjing, P. R. China.; Pancreas Institute, Nanjing Medical University, Nanjing, China.
Chen C; Department of Hepatopancreatobiliary Surgery, The Affiliated Huai'an Hospital of Xuzhou Medical University, Huai'an, China.
Li H; Changzhi Medical College, Changzhi, China.
Qu G; Changzhi Medical College, Changzhi, China.
Chen L; Changzhi Medical College, Changzhi, China.
Liu Y; Changzhi Medical College, Changzhi, China.
Zhang Y; Department of General Surgery, Pancreas Centre, the First Affiliated Hospital With Nanjing Medical University, 300 Guangzhou Road, Nanjing, P. R. China.
Zhao Q; Heping Hospital, Changzhi Medical College, Changzhi, China.
Lian C; Heping Hospital, Changzhi Medical College, Changzhi, China.
Ji A; Heping Hospital, Changzhi Medical College, Changzhi, China.
Hou X; Changzhi Medical College, Changzhi, China.
Liu X; Department of Pathogen Biology, Nanjing Medical University, Nanjing, China.
Jiang K; Department of General Surgery, Pancreas Centre, the First Affiliated Hospital With Nanjing Medical University, 300 Guangzhou Road, Nanjing, P. R. China. .; Pancreas Institute, Nanjing Medical University, Nanjing, China. .
Zhu Y; Department of General Surgery, Pancreas Centre, the First Affiliated Hospital With Nanjing Medical University, 300 Guangzhou Road, Nanjing, P. R. China. .; Pancreas Institute, Nanjing Medical University, Nanjing, China. .
He Y; Changzhi Medical College, Changzhi, China. .; Heping Hospital, Changzhi Medical College, Changzhi, China. .; Pokaż więcej
Źródło:: Molecular cancer [Mol Cancer] 2024 Jan 31; Vol. 23 (1), pp. 27. Date of Electronic Publication: 2024 Jan 31.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Pancreatic Neoplasms*/genetics
MicroRNAs*/genetics
Humans ; RNA, Circular/genetics ; Guanidinoacetate N-Methyltransferase ; Core Binding Factor Alpha 1 Subunit/genetics ; Core Binding Factor Alpha 1 Subunit/metabolism ; Transcription Factors/genetics ; Histone Deacetylases/genetics ; Histone Deacetylases/metabolism ; Apoptosis ; Cell Proliferation ; Cell Line, Tumor ; Repressor Proteins

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Oxygen glucose deprivation-pretreated astrocyte-derived exosomes attenuates intracerebral hemorrhage (ICH)-induced BBB disruption through miR-27a-3p /ARHGAP25/Wnt/β-catenin axis.
Autorzy:: Hou Y; Department of Neurology, 2nd Xiangya Hospital, Central South University, No. 139, Middle Renmin Road, Changsha, Hunan, China.
Xie Y; Department of Neurology, 2nd Xiangya Hospital, Central South University, No. 139, Middle Renmin Road, Changsha, Hunan, China.
Liu X; Department of Neurology, 2nd Xiangya Hospital, Central South University, No. 139, Middle Renmin Road, Changsha, Hunan, China.
Chen Y; Department of Neurology, 2nd Xiangya Hospital, Central South University, No. 139, Middle Renmin Road, Changsha, Hunan, China.
Zhou F; Department of Neurology, 2nd Xiangya Hospital, Central South University, No. 139, Middle Renmin Road, Changsha, Hunan, China.
Yang B; Department of Neurology, 2nd Xiangya Hospital, Central South University, No. 139, Middle Renmin Road, Changsha, Hunan, China. .; Pokaż więcej
Źródło:: Fluids and barriers of the CNS [Fluids Barriers CNS] 2024 Jan 19; Vol. 21 (1), pp. 8. Date of Electronic Publication: 2024 Jan 19.
Typ publikacji:: Journal Article
MeSH Terms:: Exosomes*/metabolism
MicroRNAs*/genetics
MicroRNAs*/metabolism
MicroRNAs*/pharmacology
Animals ; Mice ; Blood-Brain Barrier/metabolism ; Astrocytes/metabolism ; beta Catenin/metabolism ; Endothelial Cells/metabolism ; Oxygen/metabolism ; Glucose ; Cerebral Hemorrhage/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Tumor-derived small extracellular vesicles facilitate omental metastasis of ovarian cancer by triggering activation of mesenchymal stem cells.
Autorzy:: Gong L; Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Li G; Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Yi X; Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Han Q; Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.; Department of Obstetrics and Gynecology, The First College of Clinical Medical Science, China Three Gorges University, Yichang, Hubei, 443000, China.
Wu Q; Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Ying F; Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Shen L; Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.; Department of Gynecology and Obstetrics, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, Jiangsu, China.
Cao Y; Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.; Department of Obstetrics and Gynecology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Liu X; Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Gao L; Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Li W; Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Wang Z; Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. .
Cai J; Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. .; Pokaż więcej
Źródło:: Cell communication and signaling : CCS [Cell Commun Signal] 2024 Jan 17; Vol. 22 (1), pp. 47. Date of Electronic Publication: 2024 Jan 17.
Typ publikacji:: Video-Audio Media; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Ovarian Neoplasms*/pathology
Extracellular Vesicles*/metabolism
MicroRNAs*/genetics
MicroRNAs*/metabolism
Mesenchymal Stem Cells*/metabolism
Humans ; Mice ; Animals ; Female ; Neoplasm Recurrence, Local ; Cell Proliferation ; Disease Models, Animal ; Integrins/metabolism ; Cell Line, Tumor ; Tumor Microenvironment

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Prognostic value of plasma microRNAs for non-small cell lung cancer based on data mining models.
Autorzy:: Yan M; Department of Occupational and Environmental Health, College of Public Health, Zhengzhou University, Zhengzhou, China.; The Key Laboratory of Nanomedicine and Health Inspection of Zhengzhou, Zhengzhou University, Zhengzhou, China.
Kang W; Zhuji People's Hospital of Zhejiang Province, Shaoxing, China.
Liu X; Department of Occupational and Environmental Health, College of Public Health, Zhengzhou University, Zhengzhou, China.; The Key Laboratory of Nanomedicine and Health Inspection of Zhengzhou, Zhengzhou University, Zhengzhou, China.
Yang B; Department of Occupational and Environmental Health, College of Public Health, Zhengzhou University, Zhengzhou, China.; The Key Laboratory of Nanomedicine and Health Inspection of Zhengzhou, Zhengzhou University, Zhengzhou, China.
Sun N; Department of Epidemiology and Biostatistics, College of Public Health, Zhengzhou University, Zhengzhou, China.
Yang Y; Department of Epidemiology and Biostatistics, College of Public Health, Zhengzhou University, Zhengzhou, China. .
Wang W; Department of Occupational and Environmental Health, College of Public Health, Zhengzhou University, Zhengzhou, China. .; The Key Laboratory of Nanomedicine and Health Inspection of Zhengzhou, Zhengzhou University, Zhengzhou, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2024 Jan 10; Vol. 24 (1), pp. 52. Date of Electronic Publication: 2024 Jan 10.
Typ publikacji:: Journal Article
MeSH Terms:: MicroRNAs*/genetics
Carcinoma, Non-Small-Cell Lung*/genetics
Lung Neoplasms*/genetics
Humans ; Prognosis ; Prospective Studies ; Data Mining ; Biomarkers

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: The translational potential of miR-26 in atherosclerosis and development of agents for its target genes ACC1/2, COL1A1, CPT1A, FBP1, DGAT2, and SMAD7.
Autorzy:: Chen W; Cancer Institute, Department of Orthopaedics, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao Cancer Institute, Qingdao, 266071, Shandong, China.
Wu X; Cancer Institute, Department of Orthopaedics, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao Cancer Institute, Qingdao, 266071, Shandong, China.
Hu J; Department of Endocrinology, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, China.
Liu X; Department of Gastrointestinal Surgery, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, China.
Guo Z; Cancer Institute, Department of Orthopaedics, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao Cancer Institute, Qingdao, 266071, Shandong, China.
Wu J; Department of Cardiology, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Key Laboratory of Heart Failure Prevention & Treatment of Hengyang, Clinical Medicine Research Center of Arteriosclerotic Disease of Hunan Province, Hengyang, 421001, Hunan, China.
Shao Y; Cancer Institute, Department of Orthopaedics, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao Cancer Institute, Qingdao, 266071, Shandong, China.
Hao M; Cancer Institute, Department of Orthopaedics, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao Cancer Institute, Qingdao, 266071, Shandong, China.
Zhang S; Cancer Institute, Department of Orthopaedics, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao Cancer Institute, Qingdao, 266071, Shandong, China.
Hu W; Cancer Institute, Department of Orthopaedics, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao Cancer Institute, Qingdao, 266071, Shandong, China.; Department of Endocrinology, Qilu Hospital (Qingdao), Cheeloo College of Medicine, Shandong University, Qingdao, 266000, Shandong, China.
Wang Y; Cancer Institute, Department of Orthopaedics, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao Cancer Institute, Qingdao, 266071, Shandong, China.
Zhang M; Cancer Institute, Department of Orthopaedics, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao Cancer Institute, Qingdao, 266071, Shandong, China.
Zhu M; Cancer Institute, Department of Orthopaedics, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao Cancer Institute, Qingdao, 266071, Shandong, China.; Department of Neurosurgery, The Affiliated Hospital of Qingdao University, Qingdao, 266071, Shandong, China.
Wang C; Cancer Institute, Department of Orthopaedics, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao Cancer Institute, Qingdao, 266071, Shandong, China. .
Wu Y; Cancer Institute, Department of Orthopaedics, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao Cancer Institute, Qingdao, 266071, Shandong, China. .
Wang J; Cancer Institute, Department of Orthopaedics, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao Cancer Institute, Qingdao, 266071, Shandong, China. .
Xing D; Cancer Institute, Department of Orthopaedics, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao Cancer Institute, Qingdao, 266071, Shandong, China. xdm_.; School of Life Sciences, Tsinghua University, Beijing, 100084, China. xdm_.; Pokaż więcej
Źródło:: Cardiovascular diabetology [Cardiovasc Diabetol] 2024 Jan 09; Vol. 23 (1), pp. 21. Date of Electronic Publication: 2024 Jan 09.
Typ publikacji:: Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:: MicroRNAs*/genetics
Atherosclerosis*/genetics
Humans ; ADP-Ribosylation Factors ; Carotid Intima-Media Thickness ; Diacylglycerol O-Acyltransferase ; Proprotein Convertase 9 ; Smad7 Protein

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: CircPPAP2B controls metastasis of clear cell renal cell carcinoma via HNRNPC-dependent alternative splicing and targeting the miR-182-5p/CYP1B1 axis.
Autorzy:: Zheng Z; Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China.
Zeng X; Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China.
Zhu Y; Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China.
Leng M; Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China.
Zhang Z; Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China.
Wang Q; Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China.
Liu X; Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China.
Zeng S; School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, 510515, Guangdong, China.
Xiao Y; Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China.
Hu C; Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China.
Pang S; Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China.
Wang T; Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China.
Xu B; Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China.
Peng P; Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China.
Li F; Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China. .
Tan W; Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China. .; Pokaż więcej
Źródło:: Molecular cancer [Mol Cancer] 2024 Jan 06; Vol. 23 (1), pp. 4. Date of Electronic Publication: 2024 Jan 06.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Carcinoma, Renal Cell*/genetics
MicroRNAs*/genetics
Kidney Neoplasms*/genetics
Humans ; Alternative Splicing ; RNA, Circular/genetics ; Heterogeneous-Nuclear Ribonucleoproteins ; Polypyrimidine Tract-Binding Protein ; Cytochrome P-450 CYP1B1 ; Heterogeneous-Nuclear Ribonucleoprotein Group C/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Interaction between long noncoding RNA and microRNA in lung inflammatory diseases.
Autorzy:: Li J; Medical Center of Burn Plastic and Wound Repair, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Huang S; Medical Center of Burn Plastic and Wound Repair, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Shi L; Medical Center of Burn Plastic and Wound Repair, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Chen G; Medical Center of Burn Plastic and Wound Repair, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Liu X; Medical Center of Burn Plastic and Wound Repair, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Liu M; Medical Center of Burn Plastic and Wound Repair, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Guo G; Medical Center of Burn Plastic and Wound Repair, The First Affiliated Hospital of Nanchang University, Nanchang, China.; Pokaż więcej
Źródło:: Immunity, inflammation and disease [Immun Inflamm Dis] 2024 Jan; Vol. 12 (1), pp. e1129.
Typ publikacji:: Journal Article; Review
MeSH Terms:: RNA, Long Noncoding*/genetics
MicroRNAs*/genetics
Lung Neoplasms*
Humans ; Apoptosis ; Lung

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: LncTUG1 ameliorates renal tubular fibrosis in experimental diabetic nephropathy through the miR-145-5p/dual-specificity phosphatase 6 axis.
Autorzy:: Wang T; Department of Nephrology, Affiliated Hospital of Hebei University of Engineering, Hebei, China.
Cui S; The First Department of Orthopedics, Handan Central Hospital, Handan, China.
Liu X; Department of Nephrology, Affiliated Hospital of Hebei University of Engineering, Hebei, China.
Han L; Department of Nephrology, Affiliated Hospital of Hebei University of Engineering, Hebei, China.
Duan X; Department of Nephrology, Affiliated Hospital of Hebei University of Engineering, Hebei, China.
Feng S; Department of Nephrology, Affiliated Hospital of Hebei University of Engineering, Hebei, China.
Zhang S; State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, P. R. China.
Li G; Department of Nephrology, Affiliated Hospital of Hebei University of Engineering, Hebei, China.; Pokaż więcej
Źródło:: Renal failure [Ren Fail] 2023 Dec; Vol. 45 (1), pp. 2173950.
Typ publikacji:: Journal Article
MeSH Terms:: Diabetes Mellitus*
Diabetic Nephropathies*/genetics
Diabetic Nephropathies*/metabolism
Dual Specificity Phosphatase 6*/metabolism
MicroRNAs*/genetics
MicroRNAs*/metabolism
RNA, Long Noncoding*
Animals ; Mice ; Fibrosis ; Glucose ; Inflammation

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Circ_0007535 upregulates TGFBR1 to promote pulmonary fibrosis in TGF-β1-treated lung fibroblasts via sequestering miR-18a-5p.
Autorzy:: Shen M; Department of Respiratory, General Hospital of Angang Group Corporation, Anshan, Liaoning, China.
Wang X; Department of Respiratory, General Hospital of Angang Group Corporation, Anshan, Liaoning, China.
Chang X; Department of Respiratory, General Hospital of Angang Group Corporation, Anshan, Liaoning, China.
Li Z; Department of Respiratory, General Hospital of Angang Group Corporation, Anshan, Liaoning, China.
Jiang N; Department of Respiratory, General Hospital of Angang Group Corporation, Anshan, Liaoning, China.
Han Z; Department of Respiratory, General Hospital of Angang Group Corporation, Anshan, Liaoning, China.
Liu X; Department of Urology Surgery, General Hospital of Angang Group Corporation, Anshan, Liaoning, China.; Pokaż więcej
Źródło:: Autoimmunity [Autoimmunity] 2023 Dec; Vol. 56 (1), pp. 2259128. Date of Electronic Publication: 2023 Sep 19.
Typ publikacji:: Journal Article
MeSH Terms:: Pulmonary Fibrosis*/genetics
MicroRNAs*/genetics
Humans ; Receptor, Transforming Growth Factor-beta Type I/genetics ; Transforming Growth Factor beta1/genetics ; Fibroblasts ; Lung

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Exosomal miR-6733-5p mediates cross-talk between glioblastoma stem cells and macrophages and promotes glioblastoma multiform progression synergistically.
Autorzy:: Huang S; Department of Neurosurgery, Second Affiliated Hospital of Soochow University, Suzhou, China.
Liu L; Department of Neurosurgery, Affiliated Nanjing Brain Hospital, Nanjing Medical University, Nanjing, China.
Xu Z; Department of Neurosurgery, Second Affiliated Hospital of Soochow University, Suzhou, China.
Liu X; Department of Neurosurgery, Second Affiliated Hospital of Soochow University, Suzhou, China.
Wu A; Department of Neurosurgery, Second Affiliated Hospital of Soochow University, Suzhou, China.
Zhang X; Department of Neurosurgery, Second Affiliated Hospital of Soochow University, Suzhou, China.
Li Z; Department of Neurosurgery, Second Affiliated Hospital of Soochow University, Suzhou, China.
Li S; Department of Neurosurgery, Second Affiliated Hospital of Soochow University, Suzhou, China.
Li Y; Department of Neurosurgery, Second Affiliated Hospital of Soochow University, Suzhou, China.
Yuan J; Department of Neurosurgery, Second Affiliated Hospital of Soochow University, Suzhou, China.
Cheng S; Department of Neurosurgery, Second Affiliated Hospital of Soochow University, Suzhou, China.
Li H; Department of Neurosurgery, Second Affiliated Hospital of Soochow University, Suzhou, China.
Dong J; Department of Neurosurgery, Second Affiliated Hospital of Soochow University, Suzhou, China.; Pokaż więcej
Źródło:: CNS neuroscience & therapeutics [CNS Neurosci Ther] 2023 Dec; Vol. 29 (12), pp. 3756-3773. Date of Electronic Publication: 2023 Jun 12.
Typ publikacji:: Journal Article
MeSH Terms:: Glioblastoma*/pathology
MicroRNAs*/genetics
MicroRNAs*/metabolism
Humans ; Proto-Oncogene Proteins c-akt/metabolism ; Macrophages/pathology ; Stem Cells/metabolism ; Cell Line, Tumor ; Tumor Microenvironment

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: ELF5 drives angiogenesis suppression though stabilizing WDTC1 in renal cell carcinoma.
Autorzy:: Li T; School of Biology and Food Engineering, Changshu Institute of Technology, 99 Southern Sanhuan Road, Suzhou, 215500, China.; Wuxi School of Medicine, Jiangnan University, Wuxi, 214013, China.
Xu L; Department of Pathology, The Second Affiliated Hospital of Soochow University, Suzhou, 215000, China.
Wei Z; Wuxi School of Medicine, Jiangnan University, Wuxi, 214013, China.
Zhang S; Department of Pathology, The Second Affiliated Hospital of Soochow University, Suzhou, 215000, China.
Liu X; School of Biology and Food Engineering, Changshu Institute of Technology, 99 Southern Sanhuan Road, Suzhou, 215500, China.
Yang Y; School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, 310053, China. .
Gu Y; Key Laboratory of Anti-inflammatory and Immune Medicine, Ministry of Education, Institute of Clinical Pharmacology, Anhui Medical University, 81 Meishan Road, Hefei, 230032, China. .
Zhang J; School of Biology and Food Engineering, Changshu Institute of Technology, 99 Southern Sanhuan Road, Suzhou, 215500, China. .; Pokaż więcej
Źródło:: Molecular cancer [Mol Cancer] 2023 Nov 18; Vol. 22 (1), pp. 184. Date of Electronic Publication: 2023 Nov 18.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Carcinoma, Renal Cell*/genetics
Carcinoma, Renal Cell*/pathology
Kidney Neoplasms*/genetics
Kidney Neoplasms*/pathology
MicroRNAs*/genetics
Animals ; Mice ; Cell Line, Tumor ; Cell Proliferation/genetics ; DNA ; DNA Methylation ; Down-Regulation

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Intervening in hnRNPA2B1-mediated exosomal transfer of tumor-suppressive miR-184-3p for tumor microenvironment regulation and cancer therapy.
Autorzy:: Zhou X; College of pharmaceutical science, Zhejiang University, Hangzhou, 310058, China.
Hong Y; College of pharmaceutical science, Zhejiang University, Hangzhou, 310058, China.
Liu Y; College of pharmaceutical science, Zhejiang University, Hangzhou, 310058, China.; Department of Clinical Pharmacology, Affiliated Hangzhou First People's Hospital, School of Medicine, Zhejiang University, Hangzhou, 310006, China.
Wang L; College of pharmaceutical science, Zhejiang University, Hangzhou, 310058, China.
Liu X; College of pharmaceutical science, Zhejiang University, Hangzhou, 310058, China.
Li Y; College of pharmaceutical science, Zhejiang University, Hangzhou, 310058, China.
Yuan H; College of pharmaceutical science, Zhejiang University, Hangzhou, 310058, China.; Jinhua Institute of Zhejiang University, Jinhua, 321299, China.
Hu F; College of pharmaceutical science, Zhejiang University, Hangzhou, 310058, China. .; Jinhua Institute of Zhejiang University, Jinhua, 321299, China. .; Pokaż więcej
Źródło:: Journal of nanobiotechnology [J Nanobiotechnology] 2023 Nov 14; Vol. 21 (1), pp. 422. Date of Electronic Publication: 2023 Nov 14.
Typ publikacji:: Journal Article
MeSH Terms:: MicroRNAs*/genetics
MicroRNAs*/metabolism
Neoplasms*
Cell Line, Tumor ; Tumor Microenvironment ; Cell Proliferation

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Liu, X."" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język